Cannabix Technologies Achieves THC Breath Capture Milestone, Comments on Patent Portfolio

VANCOUVER, British Columbia, July 24, 2019  -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company scientists have developed proprietary methods resulting in the achievement of the highest ∆9-tetrahydrocannabinol (“THC”) detection levels collected from human breath to date. Over the last several months, Company scientists have studied the unique chemical interactions of THC and cannabinoids in breath, and developed and evaluated novel methods to efficiently and practically capture and ionize THC and cannabinoid analytes collected from several different subjects. These analytes are typically found in extremely low quantities due to their relatively low volatilities, requiring an efficient sampling method.  The Company’s newly developed methods and technologies for sample capture are an important milestone and represent a significant advancement in the field of human breath studies. These novel capture methods could have implications for both point-of-care and lab-based instruments that would provide real-time results from breath samples, targeting analytes of a wide range of volatilities. The Company continues to expeditiously conduct trial testing to evaluate the sensitivity and accuracy of the instrument and to collect data to determine variance among test subjects at its Vancouver and Florida development facilities using its FAIMS (field asymmetric waveform ion mobility spectrometry) THC detection device.
Read more: Cannabix Technologies ( BLO )

World Class and Quadron Announce Closing of Plan of Arrangement

Also News Release (C-QCC) Quadron Cannatech Corp
 
TORONTO and VANCOUVER, British Columbia, June 17, 2019  -- World Class Extractions Inc. (“World Class”) (CSE: PUMP) and Quadron Cannatech Corporation (“Quadron”) (CSE: QCC) are pleased to announce that that they have completed their previously announced plan of arrangement (the “Arrangement”) under the provisions of the Business Corporations Act (British Columbia), pursuant to which World Class has acquired all of the common shares of Quadron (the “Quadron Shares”) following Quadron’s amalgamation with World Class’s wholly-owned subsidiary, 1212476 B.C. LTD., to form a new wholly-owned subsidiary of World Class continuing as “Quadron Cannatech Corporation” (“Amalco”).
 
“The merger of Quadron Cannatech with World Class Extractions accelerates the pace and effectively increases progress towards our strategic goals of becoming the world’s largest extraction company in terms of capacity,” said Rosy Mondin, the new Chief Executive Officer of World Class. “The reconstituted management and board have diverse and strategically-relevant backgrounds to address the global opportunities arising in the cannabis and hemp industries.”
Read more: World Class Extractions ( PUMP )

World Class and Quadron Announce Approval of Quadron Shareholders to Plan of Arrangement

Toronto, Ontario–(June 10, 2019) – World Class Extractions Inc. (CSE: PUMP) (“World Class“) and Quadron Cannatech Corporation (“Quadron“) (CSE: QCC) are pleased to announce that, at the special meeting of the shareholders of Quadron held on June 7, 2019 (the “Meeting“), the shareholders of Quadron voted in favour of a special resolution to approve the proposed transaction, pursuant to which, among other things, World Class will acquire all of the issued and outstanding shares of Quadron, by way of a court-approved plan of arrangement (the “Arrangement“) as previously announced on April 16, 2019.
 
The Arrangement required approval by (i) at least two-thirds of the votes cast by holders (“Quadron Shareholders“) of common shares in the capital of Quadron (“Quadron Shares“) present in person or by proxy at the Meeting, and (ii) a majority of the votes cast excluding the votes of Quadron Shares held or controlled by “interested parties” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions. At the Meeting, the Arrangement was approved by (i) 99.97% of the votes cast by all of the Quadron Shareholders eligible to vote at the Meeting, and (ii) 99.96% of the votes cast by all of the Quadron Shareholders eligible to vote at the Meeting excluding votes of Quadron Shares held or controlled by interested parties. Approximately 37% of the total issued and outstandring Quadron Shares were voted in person or proxy at the Meeting.
Read more: World Class Extractions ( PUMP )

Cannabix Technologies Makes Advances with Marijuana Breathalyzer Development and Renews Research with Yost Group

VANCOUVER, British Columbia, May 29, 2019 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company engineers have made a significant breakthrough with the ionization module which is a vital component of the breathalyzer device, where breath samples are ionized prior to entrance into the FAIMS cell. New ion focussing techniques have resulted in a 30% increase in ion current and transmission/signal strength in testing, further increasing instrument sensitivity. The Company also reports that it has been steadily progressing with human breath testing at its Vancouver, BC, based lab with its FAIMS (field asymmetric waveform ion mobility spectrometry) ∆9-tetrahydrocannabinol (“THC”) detection device and breath collection unit (“BCU”). Testing and refinement of the BCU over the last 30 days has led to upgrades in flow and CO2 sensor components as well as refinements in breath analysis from various users. Furthermore, engineers are developing an improved detector component for the system and a smaller footprint for the ionization chamber. These upgrades are being made in preparation for a design freeze of the prototype and multi device creation for additional testing. The Company is also preparing new marketing materials of its device for potential pilot users.
Read more: Cannabix Technologies ( BLO )

FSD Pharma, Solarvest to develop CBDs out of algae

See News Release (C-HUGE) FSD Pharma Inc
 
PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(S)
 
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (“FSD Pharma”) and Solarvest BioEnergy Inc. (TSX-V: SVS) (“Solarvest”) (collectively, the “Parties”), a technology company which has developed an algal-based flexible production platform capable of producing health products, are pleased to announce that they have signed a non-binding letter of intent (“LOI”). The parties intend to enter into a definitive agreement (the “Collaborative Research Agreement”), under which Solarvest would conduct research using its algal expression technology to develop pharma-grade cannabinoids (the “Project Cannabinoids”), the Parties would make mutual investments into one another, and Solarvest would grant FSD Pharma an exclusive license over a subset of the Project Cannabinoids and certain royalty rights over all of the other Project Cannabinoids.
Read more: Solarvest BioEnergy ( SVS )

Videos / Webinars

View all videos